Transcriptional Dysregulation Study Reveals a Core Network Involving the Progression of Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: The pathogenesis of Alzheimer's disease is associated with dysregulation at different levels from transcriptome to cellular functioning. Such complexity necessitates investigations of disease etiology to be carried out considering multiple aspects of the disease and the use of independent strategies. The established works more emphasized on the structural organization of gene regulatory network while neglecting the internal regulation changes. Methods: Applying a strategy different from popularly used co-expression network analysis, this study investigated the transcriptional dysregulations during the transition from normal to disease states. Results: 97 genes were predicted as dysregulated genes, which were also associated with clinical outcomes of Alzheimer's disease. Both the co-expression and differential co-expression analysis suggested these genes to be interconnected as a core network and that their regulations were strengthened during the transition to disease states. Functional studies suggested the dysregulated genes to be associated with aging and synaptic function. Further, we checked the evolutionary conservation of the gene co-expression and found that human and mouse brain might have divergent transcriptional co-regulation even when they had conserved gene expression profiles. Conclusion: Overall, our study reveals a core network of transcriptional dysregulation associated with the progression of Alzheimer's disease by affecting the aging and synaptic functions related genes; the gene regulation is not conserved in the human and mouse brains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · cited 1×
“transcriptome to neuronal function (Minati et al., 2009; Huang and Mucke, 2012).”
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744 · cited 1×
“As the population ages, AD will impact more people and place an increasing economic burden on society (Cummings et al., 2014; Alzheimer’s, 2015).”
BackgroundIntegrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · cited 1×
“A significant challenge is the poor understanding of the etiology of this disease (Krstic and Knuesel, 2013; Karch and Goate, 2015; Kumar et al., 2015).”
BackgroundBouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 1×
“Another example was the TREM2 gene, which was reported to get involved in the neuroimmunology of AD (Bouchon et al., 2000).”
BackgroundEigengene networks for studying the relationships between co-expression modules
Langfelder, P., & Horvath, S. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-54 · Cited by 867 · cited 1×
“The coregulated clusters in the network provide the chance to track the affected pathways or biological processes in diseases (Langfelder and Horvath, 2007).”
BackgroundCoexpression Analysis of Human Genes Across Many Microarray Data Sets
Lee, H. K., Hsu, A. K., Sajdak, J., Qin, J., & Pavlidis, P. (2004) · Genome Research · doi:10.1101/gr.1910904 · Cited by 770
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685 · cited 1×
“Another way is to associate the subnetwork expression to disease progresses or clinical traits, which can uncover the regulatory components involved in the dysregulation of diseases (McKinney et al., 2015).”
BackgroundDivergence of human and mouse brain transcriptome highlights Alzheimer disease pathways
Miller, J. A., Horvath, S., & Geschwind, D. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914257107 · Cited by 480 · cited 2×
“One of the most popular strategies is to find the topological structural changes of the co-expression network under different disease states where these changes indicate regulatory dysregulation in the disease (Miller et al., 2010; Narayanan et al., 2014).”
BackgroundA survey of genetic human cortical gene expression
Myers, A. J., Gibbs, J. R., Webster, J. A., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., Leung, D., Bryden, L., Nath, P., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.16 · Cited by 479 · cited 1×
“(AMP-AD) program (provides an opportunity to study the altered transcriptional regulation during the progression of AD (Myers et al., 2007; Webster et al., 2009; Zou et al., 2012; Zhang et al., 2013).”
BackgroundDeciphering the mechanism underlying late-onset Alzheimer disease
Krstic, D., & Knuesel, I. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.236 · Cited by 457 · cited 1×
“A significant challenge is the poor understanding of the etiology of this disease (Krstic and Knuesel, 2013; Karch and Goate, 2015; Kumar et al., 2015).”
BackgroundGenetic Control of Human Brain Transcript Expression in Alzheimer Disease
Webster, J. A., Gibbs, J. R., Clarke, J., Ray, M., Zhang, W., Holmans, P., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.011 · Cited by 304
Guidance for RNA-seq co-expression network construction and analysis: safety in numbers
Ballouz, S., Verleyen, W., & Gillis, J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv118 · Cited by 215
Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases
Narayanan, M., Huynh, J. L., Wang, K., Yang, X., Yoo, S., McElwee, J., Zhang, B., Zhang, C., Lamb, J. R., Xie, T., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145304 · Cited by 208
Oldham, M. C., Langfelder, P., & Horvath, S. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-63 · Cited by 154
Comparative study of RNA-seq- and Microarray-derived coexpression networks in Arabidopsis thaliana
Giorgi, F. M., Del Fabbro, C., & Licausi, F. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt053 · Cited by 103 · cited 1×
“INTRODUCTION Alzheimer’s disease (AD) is a neurodegenerative disorder most prevalent in people over the age of 65 years (Lashuel et al., 2002; Goedert and Spillantini, 2006; Prince et al., 2013).”
BackgroundNemo‐like kinase is involved in NGF‐induced neurite outgrowth via phosphorylating MAP1B and paxillin
Ishitani, T., Ishitani, S., Matsumoto, K., & Itoh, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06400.x · Cited by 46
Cited by
Joint profiling of histone modifications and transcriptome in single cells from mouse brain
Zhu, C., Zhang, Y., Li, Y. E., Lucero, J., Behrens, M. M., & Ren, B. (2021) · Nature Methods · doi:10.1038/s41592-021-01060-3 · Cited by 301
Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226
“Overall, 97 genes were found to be dysregulated and associated with the clinical outcome in AD [130].”
BackgroundCai, S., Huang, K., Yang, F., Wang, X., Wu, S., Wang, Y., & Huang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.745381 · Cited by 11
Sebastian, S., Roy, S., & Kalita, J. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104797 · Cited by 10
Metadata
- Authors
- Meng, G., & Mei, H.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-05-07
- Volume
- 11
- Pages
- 101-101
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2951116758
- Cited by
- 28
- References
- 18
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.